Neurotech Historical Cash Flow

NTI Stock

0.07 0 1.45%

Analysis of Neurotech International cash flow over time is an excellent tool to project Neurotech International future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Depreciation of 31.6 K or Capital Expenditures of 337.5 K as it is a great indicator of Neurotech International ability to facilitate future growth, repay debt on time or pay out dividends.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Neurotech International latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Neurotech International is a good buy for the upcoming year.

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neurotech International. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About Neurotech Cash Flow Analysis

The Cash Flow Statement is a financial statement that shows how changes in Neurotech balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Neurotech's non-liquid assets can be easily converted into cash.

Neurotech International Cash Flow Chart

At this time, Neurotech International's Net Borrowings is comparatively stable compared to the past year. Depreciation is likely to gain to about 31.6 K in 2024, whereas Change In Cash is likely to drop slightly above 1.9 M in 2024.

Net Borrowings Other Cashflows From Financing Activities End Period Cash Flow Change To Netincome Stock Based Compensation Dividends Paid

Net Borrowings

The difference between the amount of new debt a company has taken on and the amount of debt it has paid off during a given period.

Stock Based Compensation

Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.

Dividends Paid

The total amount of dividends that a company has paid out to its shareholders over a specific period.

Most accounts from Neurotech International's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Neurotech International current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neurotech International. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Neurotech International cash flow statement Correlations

	Sale Purchase Of Stock	Change To Inventory	Change In Cash	Net Borrowings	Depreciation	Capital Expenditures	Change To Account Receivables	Change To Operating Activities	Net Income	End Period Cash Flow	Change To Netincome	Change To Liabilities	Stock Based Compensation	Free Cash Flow	Change In Working Capital	Begin Period Cash Flow	Other Non Cash Items	Investments	Dividends Paid	Issuance Of Capital Stock
Sale Purchase Of Stock		0.13	0.17	0.57	-0.34	0.11	-0.55	-0.01	-0.39	0.19	-0.14	0.53	0.0	-0.63	0.06	0.12	0.0	0.19	0.31	0.45
Change To Inventory	0.13		0.37	-0.1	-0.43	0.07	-0.26	-0.07	-0.47	0.42	0.26	-0.49	0.15	-0.61	-0.29	0.3	0.16	0.15	-0.23	-0.03
Change In Cash	0.17	0.37		-0.03	-0.44	0.56	-0.53	-0.39	-0.42	0.85	0.45	-0.12	0.69	-0.46	-0.62	0.07	0.16	0.34	0.48	0.73
Net Borrowings	0.57	-0.1	-0.03		-0.36	0.32	-0.39	0.09	0.24	0.13	-0.3	0.3	-0.03	-0.23	-0.26	0.59	0.28	0.13	0.39	0.19
Depreciation	-0.34	-0.43	-0.44	-0.36		-0.17	0.18	-0.23	0.49	-0.5	-0.4	-0.1	-0.36	0.55	0.27	-0.38	0.01	-0.84	-0.31	-0.56
Capital Expenditures	0.11	0.07	0.56	0.32	-0.17		-0.18	-0.27	-0.07	0.81	-0.13	-0.2	0.24	-0.23	-0.69	0.48	0.51	0.11	0.38	0.45
Change To Account Receivables	-0.55	-0.26	-0.53	-0.39	0.18	-0.18		-0.02	0.27	-0.34	-0.28	-0.29	-0.55	0.39	0.26	0.06	-0.03	0.07	-0.49	-0.36
Change To Operating Activities	-0.01	-0.07	-0.39	0.09	-0.23	-0.27	-0.02		-0.17	-0.31	0.2	0.21	-0.03	0.17	0.38	-0.19	-0.22	0.22	-0.02	-0.17
Net Income	-0.39	-0.47	-0.42	0.24	0.49	-0.07	0.27	-0.17		-0.5	-0.52	-0.33	-0.47	0.56	-0.1	0.18	0.33	-0.49	-0.24	-0.49
End Period Cash Flow	0.19	0.42	0.85	0.13	-0.5	0.81	-0.34	-0.31	-0.5		0.2	-0.13	0.52	-0.54	-0.64	0.38	0.18	0.4	0.53	0.67
Change To Netincome	-0.14	0.26	0.45	-0.3	-0.4	-0.13	-0.28	0.2	-0.52	0.2		0.14	0.84	-0.03	-0.12	-0.35	-0.01	0.34	0.0	0.29
Change To Liabilities	0.53	-0.49	-0.12	0.3	-0.1	-0.2	-0.29	0.21	-0.33	-0.13	0.14		0.27	-0.04	0.43	-0.28	-0.48	0.2	0.52	0.37
Stock Based Compensation	0.0	0.15	0.69	-0.03	-0.36	0.24	-0.55	-0.03	-0.47	0.52	0.84	0.27		-0.1	-0.34	-0.18	0.0	0.26	0.43	0.5
Free Cash Flow	-0.63	-0.61	-0.46	-0.23	0.55	-0.23	0.39	0.17	0.56	-0.54	-0.03	-0.04	-0.1		0.41	-0.5	-0.07	-0.54	-0.25	-0.57
Change In Working Capital	0.06	-0.29	-0.62	-0.26	0.27	-0.69	0.26	0.38	-0.1	-0.64	-0.12	0.43	-0.34	0.41		-0.66	-0.68	-0.26	-0.18	-0.44
Begin Period Cash Flow	0.12	0.3	0.07	0.59	-0.38	0.48	0.06	-0.19	0.18	0.38	-0.35	-0.28	-0.18	-0.5	-0.66		0.46	0.34	0.12	0.14
Other Non Cash Items	0.0	0.16	0.16	0.28	0.01	0.51	-0.03	-0.22	0.33	0.18	-0.01	-0.48	0.0	-0.07	-0.68	0.46		-0.13	-0.41	-0.01
Investments	0.19	0.15	0.34	0.13	-0.84	0.11	0.07	0.22	-0.49	0.4	0.34	0.2	0.26	-0.54	-0.26	0.34	-0.13		0.37	0.71
Dividends Paid	0.31	-0.23	0.48	0.39	-0.31	0.38	-0.49	-0.02	-0.24	0.53	0.0	0.52	0.43	-0.25	-0.18	0.12	-0.41	0.37		0.66
Issuance Of Capital Stock	0.45	-0.03	0.73	0.19	-0.56	0.45	-0.36	-0.17	-0.49	0.67	0.29	0.37	0.5	-0.57	-0.44	0.14	-0.01	0.71	0.66

Click cells to compare fundamentals

Neurotech International Account Relationship Matchups

Neurotech International cash flow statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Sale Purchase Of Stock	(240K)	(75.0K)	(443.5K)	26.4K	9.4M	1.3M
Change To Inventory	9.8K	71.0K	(428.9K)	(7.2K)	(579.0)	7.8K
Change In Cash	(1.7M)	(462.3K)	4.8M	(2.9M)	1.1M	6.6M
Net Borrowings	(373.5K)	96.3K	220.5K	(46.6K)	1.3M	1.3M
Other Cashflows From Financing Activities	3.4M	997.6K	220.5K	(3.2K)	9.4M	1.0
Depreciation	2.0K	81.1K	1.7K	588.0	1.7K	583.0
Total Cash From Operating Activities	(2.5M)	(682.8K)	(2.3M)	(3.0M)	(6.3M)	(4.6M)
Change To Account Receivables	130.1K	116.4K	(116.8K)	43.5K	(158.1K)	(60.5K)
Change To Operating Activities	54.3K	(10.1K)	(772.0)	42.7K	1.4K	(51.5K)
Net Income	(4.8M)	(1.7M)	(7.4M)	(3.4M)	(7.8M)	(5.1M)
Total Cash From Financing Activities	805.0K	220.5K	7.1M	26.4K	9.4M	11.2M
End Period Cash Flow	474.7K	12.4K	4.8M	1.9M	3.0M	11.6M
Change To Netincome	2.1M	404.3K	4.8M	84.0K	876.6K	1.3M
Change To Liabilities	(116.6K)	438.9K	471.5K	244.1K	753.9K	15.4K
Stock Based Compensation	129.3K	5.0M	84.0K	876.6K	2.2M	1.2M
Free Cash Flow	(682.8K)	(2.3M)	(3.0M)	(6.3M)	(4.6M)	(4.8M)
Change In Working Capital	545.2K	(116.8K)	323.1K	596.6K	(1.7M)	(1.6M)
Begin Period Cash Flow	474.7K	12.4K	4.8M	1.9M	5.0M	5.3M
Other Non Cash Items	11.1K	240.0K	(195.9K)	284.9K	2.2M	2.3M
Dividends Paid	3.1M	730.0K	7.2M	7.1M	8.2M	5.1M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Neurotech Stock Analysis

When running Neurotech International's price analysis, check to measure Neurotech International's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neurotech International is operating at the current time. Most of Neurotech International's value examination focuses on studying past and present price action to predict the probability of Neurotech International's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neurotech International's price. Additionally, you may evaluate how the addition of Neurotech International to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC